• According to estimates from 19 analysts, Teladoc Health, Inc. stock's average price target has risen from $7.76 to $7.84, with forecasts ranging from $5 to $11 per share
  • Based on the Jul. 29 closing price, the updated target implies approximately 15% potential downside
  • Consensus rating remains at “Hold” across 25 covering analysts, with 5 Buys, 19 Holds and 1 Sells

Explore more price target data and ratings for Teladoc Health, Inc. on the , and track all previous and future analyst recommendations for Teladoc Health, Inc. in the dedicated .

Select reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc. This information is not a recommendation for what you should do personally and does not constitute investment advice.